Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H19F3N6O |
Molecular Weight | 380.3676 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@H]1CN(C[C@@H]1C2=CN=C3C=NC4=C(C=CN4)N23)C(=O)NCC(F)(F)F
InChI
InChIKey=WYQFJHHDOKWSHR-MNOVXSKESA-N
InChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/t10-,11+/m1/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1967
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
522916
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
524116
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
575517
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CD-19
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
2196092
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
10209
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
Upadacitinib
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
100000173002
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
5346
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
4RA0KN46E0
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
58557659
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
DB15091
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
4RA0KN46E0
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
C152802
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
m12178
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
1310726-60-3
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
Upadacitinib
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY | |||
|
DTXSID901027919
Created by
admin on Sat Dec 16 08:54:19 UTC 2023 , Edited by admin on Sat Dec 16 08:54:19 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE INACTIVE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)